MVA-BN-HER2
Alternative Names: HER-2 DNA AutoVac; MVA-BN Breast; MVA-BN-HER2; MVA-BN/Her-2/Neu; PX 103.2; PX-1032Latest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Pharmexa
- Developer Bavarian Nordic
- Class Cancer vaccines
- Mechanism of Action ERBB 2 receptor antagonists; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Breast cancer